Loncar Cancer Immunotherapy Etf Price History
If you're considering investing in Loncar Etf, it is important to understand the factors that can impact its price. Loncar Cancer Immuno has Sharpe Ratio of -0.14, which conveys that the entity had a -0.14% return per unit of risk over the last 3 months. Loncar Cancer exposes fifteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Loncar Cancer's Risk Adjusted Performance of (0.10), mean deviation of 1.62, and Standard Deviation of 2.09 to check out the risk estimate we provide.
Loncar Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
Loncar |
Sharpe Ratio = -0.1387
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNCR |
Estimated Market Risk
| 2.09 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Loncar Cancer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Loncar Cancer by adding Loncar Cancer to a well-diversified portfolio.
Loncar Cancer Etf Price History Chart
There are several ways to analyze Loncar Cancer Immunotherapy Etf price data. The simplest method is using a basic Loncar candlestick price chart, which shows Loncar Cancer price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
No Historical data is available at this time
| TWII | 2.64 | ||||
| IDX 30 | 2.54 | ||||
| BELS | 2.34 | ||||
| APACXJ | 2.30 | ||||
| PSEI | 2.01 | ||||
| BETNG | 1.94 | ||||
| AXDI | 1.76 | ||||
| SET | 1.60 | ||||
| Tel Aviv | 1.01 | ||||
| Budapest | 0.95 | ||||
| KLTE | 0.82 | ||||
| SLI | 0.79 | ||||
| OSEFX | 0.54 | ||||
| ATX | 0.50 | ||||
| NYA | 0.46 | ||||
| PSI 20 | 0.46 | ||||
| HNX 30 | 0.42 | ||||
| CROBEX | 0.17 | ||||
| WIG 30 | 0.13 | ||||
| MERV | 0.00 | ||||
| ISEQ 20 | 0.14 | ||||
| GDAXI | 0.18 | ||||
| ATG | 0.25 | ||||
| CFMDIVO | 0.25 | ||||
| IBEX 35 | 0.28 | ||||
| MXX | 0.34 | ||||
| PX | 0.44 | ||||
| IMAT | 0.52 | ||||
| ASCX | 0.92 | ||||
| XELKT | 1.81 |
About Loncar Cancer Etf history
Loncar Cancer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Loncar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Loncar Cancer Immuno will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Loncar Cancer stock prices may prove useful in developing a viable investing in Loncar Cancer
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the funds index provider, as having a high strategic focus on the development of drugs that harness the bodys own immune system to fight cancer. Loncar Cancer is traded on NASDAQ Exchange in the United States.
Loncar Cancer Etf Technical Analysis
Loncar Cancer technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Loncar Cancer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Loncar Cancer's price direction in advance. Along with the technical and fundamental analysis of Loncar Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Loncar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | (1.19) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Loncar Cancer Immunotherapy. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.